Horizon Technology Finance Faces Two New Lawsuits Challenging Monroe Capital Merger Ahead of Shareholder Vote
Summary
Horizon Technology Finance Corp. disclosed two new lawsuits alleging material omissions in the merger prospectus for its proposed combination with Monroe Capital Corporation, seeking to enjoin the transaction before the March 13 shareholder vote.
Key Events
-
Two New Lawsuits Filed
Horizon Technology Finance Corp. disclosed two new complaints filed in New York by Christopher Scott and Dan Clark against the company and its directors.
-
Merger Prospectus Challenged
The lawsuits allege that the Form 424B3 Prospectus, filed on January 20, 2026, for the merger with Monroe Capital Corporation, is materially incomplete and misleading.
-
Alleged Material Omissions
Plaintiffs claim the prospectus omits critical financial projections for HRZN (standalone and pro forma) and MRCC, as well as key data and inputs for Oppenheimer's fairness opinion.
-
Injunction Sought Ahead of Vote
The lawsuits seek to enjoin the proposed merger until the alleged material information is disclosed, or to recover damages if the transaction is consummated. The shareholder vote is scheduled for March 13, 2026.
Analysis
Horizon Technology Finance Corp. is facing increased legal pressure regarding its proposed merger with Monroe Capital Corporation. This filing discloses two additional lawsuits, filed by Christopher Scott and Dan Clark, which allege that the January 20, 2026, merger prospectus (424B3) contains material omissions. Specifically, the plaintiffs claim a lack of crucial financial projections for both HRZN and MRCC, as well as insufficient data underlying Oppenheimer's fairness opinion. These lawsuits seek to enjoin the merger, which is particularly critical given the shareholder vote on the share issuance for the transaction is scheduled for March 13, 2026. This development follows a prior class action lawsuit disclosed on February 6, 2026, further escalating the legal and operational risks surrounding the merger.
At the time of this filing, HRZN was trading at $5.95 on NASDAQ in the Unknown sector, with a market capitalization of approximately $293.6M. The 52-week trading range was $5.71 to $9.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.